BIOCARDIA
BioCardia is a clinical-stage regenerative medicine company. We are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. BioCardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its CardiAMPâ„¢ and CardiALLOâ„¢ therapies. Clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with intramyocardial delivery of marrow-derived cells.
BIOCARDIA
Industry:
Alternative Medicine Biotechnology Medical Therapeutics
Founded:
1999-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.biocardia.com
Total Employee:
11+
Status:
Active
Contact:
6506313731
Total Funding:
7.4 M USD
Technology used in webpage:
SPF LetsEncrypt Content Delivery Network Apache Euro Amazon JsDelivr PHP PHP 7 BootstrapCDN
Similar Organizations
Accelerated Biosciences
Accelerated Biosciences is a regenerative medicine company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Healshape
Healshape is a 3D bioprinting regenerative medecine company.
Morphocell Technologies
Morphocell Technologies is a regenerative medicine company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.biocardia.com Semrush global rank: 1.99 M Semrush visits lastest month: 10.71 K
- Host name: 158.178.197.197
- IP address: 158.178.197.197
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "BioCardia"
about us - BioCardia
About BioCardia. We are developing cellular and cell-derived therapeutics for the treatment of unmet cardiovascular and pulmonary diseases. Our Mission: To improve the lives of patients …See details»
BioCardia
The contents of the Site may not be distributed, modified, reproduced, or used, in whole or in part, without the prior written consent of BioCardia. Any copies of material or other content provided through the Site must include the same …See details»
BioCardia - Crunchbase Company Profile & Funding
BioCardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its CardiAMPâ„¢ and CardiALLOâ„¢ therapies. Clinical …See details»
Careers - BioCardia
We provide service and support to our communities as an organization and as individuals. We celebrate our accomplishments regularly and aim to have fun every day; Open positions - …See details»
BioCardia, Inc. - LinkedIn
BioCardia, Inc. Biotechnology Research Sunnyvale, California 4,622 followers a leader in the development of comprehensive solutions for cardiovascular regenerative therapiesSee details»
BioCardia, Inc. - AnnualReports.com
BioCardia, Inc., headquartered in San Carlos, California, is developing autologous and allogenic cell-based therapies to treat cardiovascular disease. CardiAMPâ„¢ and CardiALLOâ„¢ cell …See details»
BioCardia, Inc. Company Profile | Sunnyvale, CA | Competitors ...
The therapy is enabled by BioCardia's Helix delivery system, through which treatments are injected into the walls... Read More of the heart. The firm has other regenerative biologic …See details»
BioCardia (BCDA) Company Profile & Description - Stock Analysis
2 days ago BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. …See details»
BioCardia Inc Company Profile - Overview - GlobalData
BioCardia Inc (BioCardia) is a regenerative medicine company. The company's pipeline products include autologous BCDA-01 and NK1R+ Allogeneic BCDA-03 is for the treatment of ischemic …See details»
BioCardia, Inc. - MSCRF
BioCardia's mission is to bring to market comprehensive cell therapy solutions for the treatment of cardiovascular diseases with large unmet medical needs. BioCardia is a clinical-stage regenerative medicine company. BioCardia lead …See details»
BioCardia - Products, Competitors, Financials, Employees, …
BioCardia, headquartered in San Carlos, CA, is a privately-held company developing regenerative biologic therapies to treat cardiovascular disease. The Company's products include the Helix …See details»
BioCardia Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 BioCardia has 3 employees at their 1 location and $477 k in annual revenue in FY 2023. See insights on BioCardia including office locations, competitors, revenue, financials, …See details»
bcda20240331_10q.htm - SEC.gov
Mar 31, 2024 incorporation or organization) ... BioCardia, Inc. (we, us, our, BioCardia or the Company), is a clinical-stage company focused on developing cellular and cell-derived …See details»
Management Team - BioCardia
BioCardia's management team gathers together industry veterans with a wealth of experience and a commitment to driving BioCardia forward to improve the lives of patients with …See details»
BioCardia, Inc. (BCDA): history, ownership, mission, how it works ...
Could BioCardia, Inc. (BCDA), a clinical-stage company laser-focused on cardiovascular regenerative medicine, truly reshape how we treat heart disease using its proprietary …See details»
Mission Statement, Vision, & Core Values of BioCardia, Inc. (BCDA)
BioCardia maintains open communication with stakeholders, including patients, healthcare providers, and investors, to foster trust and accountability. ... is evident in their robust …See details»
BioCardia Announces First Patient in Phase 3 Randomized …
4 days ago BioCardia, Inc., headquartered in Sunnyvale, California, is a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease.See details»
About Biocardia Inc (BCDA) - Investing.com
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.See details»
Investor Information - BioCardia
The contents of the Site may not be distributed, modified, reproduced, or used, in whole or in part, without the prior written consent of BioCardia. Any copies of material or other content provided …See details»
First subject enrolled in BioCardia’s heart failure therapy trial
2 days ago BioCardia has announced the enrolment of the first subject in the randomised, double-blind, placebo-controlled Phase III CardiAMP heart failure (HF) II trial of its autologous …See details»